Congress, Safety, Heparin and Hearing on the Hill

Reuters video regarding yesterday’s hearing:

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Legislation. Bookmark the permalink.

One Response to Congress, Safety, Heparin and Hearing on the Hill

  1. Ajlouny says:

    The FDA has a tough line to walk to try and get medications to people that can receive benefit, but not so early as to miss major problems. When side effects occur only in 0.1% of the subjects, you need to have 10s of thousands of subjects to really see it become statistically significant from placebo. Yes, it is sad that this happens, but there is just no way to prove that drugs are conclusively safe before they are approved.